nuroflux™ technology has been developed with key opinion leaders in stroke and biomedical engineers.
The nuroflux™ device utilises a proprietary multi-modal system to provide simultaneous monitoring of brain activity (via electroencephalography) and brain blood flow (via a novel electrocardiography-based metric).
A feasibility study has been published detailing our novel electrocardiography-based metric in healthy volunteers:
https://link.springer.com/article/10.1007/s13534-023-00265-z
Multiple modalities allow for rich datasets, deep-learning analysis and the creation of predictive models.